Trial Profile
A Human Phase I Absolute Bioavailability Study of PRT054021 in Healthy Male Volunteers.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 24 Jan 2013
Price :
$35
*
At a glance
- Drugs Betrixaban (Primary) ; Betrixaban (Primary)
- Indications Stroke; Thromboembolism
- Focus Pharmacokinetics
- Sponsors Portola Pharmaceuticals
- 24 Jan 2013 New trial record